Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
BMJ Open|January 26, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocolHeidrun Golla, Kim Dillen, Martin Hellmich, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 7, 2020
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosisSargis Abrahamyan, Bettina Eberspächer, Muna-Miriam Hoshi, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Pageof 13